Hiring a pharma digital agency is not hiring a marketing agency that happens to have life sciences logos on its site. Prescription drug promotion is regulated, reviewed and archived, and the agencies that survive in it are built around that fact: they know what a medical, legal and regulatory review cycle does to a production schedule, they write to fair balance rather than around it, and they understand that the same claim can be fine for a physician audience and unacceptable for a consumer one. This guide covers what changes in a regulated engagement, what moves the price, and how to check a candidate on evidence rather than on the size of its client list.
What makes pharma work different
Prescription drug advertising is overseen by the FDA, whose own explainer for consumers sets out the basic requirement that advertising for a prescription product must present benefit and risk information in a balanced way, and its Office of Prescription Drug Promotion enforces that in practice. For an agency, this changes the shape of every deliverable. Copy is written against an approved label rather than a creative brief. Claims trace to references, and the reference pack travels with the asset. Nothing publishes without medical, legal and regulatory sign-off, and every version is archived because it may be asked for later. Even the mechanics change: a banner cannot rotate a claim without a corresponding risk statement, and an unbranded disease awareness site has to stay genuinely unbranded. An agency that talks about growth hacking and shipping fast is describing a workflow this industry does not have.
HCP work and consumer work are separate trades
Promotion aimed at healthcare professionals and promotion aimed at patients look like the same discipline and are not. Professional work is technical, references heavily, lives on gated portals, congress activity, email and paid media against verified professional audiences, and is judged on share of voice among a small, well-defined population. Consumer work is broader, must carry risk information far more prominently, and runs into a second regulator: the FTC's guidance on health-related claims and endorsements applies to how any testimonial or influencer content is presented. Some agencies do both competently; many do one well and subcontract the other. Ask which of the two the named team on your account has actually shipped, and ask to see an example that went through review, not a concept deck.
What moves the price
Review burden is the largest single driver, and it is a multiplier rather than a line item. An asset that needs three review rounds costs materially more than the same asset in an unregulated category, and agencies price that expectation in whether or not they itemise it. Scale is next: one product in one market is a different engagement from a portfolio across several markets, each with its own local rules. Then comes the mix. Content and web builds are project priced, media is usually a fee plus spend, and ongoing brand support is a retainer. Buyers comparing quotes should insist on seeing which model applies to which element, because a blended monthly number hides whether you are paying for people, production or media. Pricing in this market rewards the buyer who asks for the fee basis before the total.
How to vet a candidate
Ask three questions that are hard to answer with a deck. First: describe your review workflow, including who prepares the reference pack and how many rounds you budget for. A real answer includes numbers and a named role. Second: show me an asset that shipped, with the risk information in place, and tell me what changed between the first submission and approval. Third: who on the named team has worked on a launch, and will they still be on the account in month six. Then do the checks that apply to any agency: is pricing or a minimum disclosed anywhere, are the client names verifiable, and does the contract leave you owning the sites, the analytics and the archived assets. The absence of published evidence is itself information.
Questions people ask about pharma digital agency
Do I need a specialist, or can a generalist agency learn?
A generalist can learn the digital craft; what they cannot improvise is the review workflow and the habits that come with it. If your product is prescription-only, buy the specialist for regulated assets and consider a generalist only for unbranded corporate or recruitment work where the constraints are ordinary.
How long do timelines really run?
Assume that any regulated asset takes longer than the production time suggests, because review rounds sit between drafts and each round has a queue. Agencies that quote aggressive dates without naming the review assumption are quoting production only. Ask for a schedule that shows submission dates, not just delivery dates.
What should the contract cover that a normal one would not?
Archiving and transfer of approved assets with their reference packs, clarity on who holds regulatory responsibility for submissions, data handling terms that match your privacy obligations, and a named team with change-of-personnel notice. Ordinary marketing contracts cover none of these well.
How is this priced compared with an ordinary digital agency?
Higher, and the gap is mostly review overhead and specialist people rather than margin. The useful comparison is not the monthly number but the fee basis behind it. Ask which parts are project priced, which are retainer and which are media fee plus spend, and compare candidates line by line on that.